EyePoint Pharmaceuticals, Inc. Quarterly Marketable Securities, Current in USD from Q2 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
EyePoint Pharmaceuticals, Inc. quarterly Marketable Securities, Current history and growth rate from Q2 2011 to Q2 2024.
  • EyePoint Pharmaceuticals, Inc. Marketable Securities, Current for the quarter ending June 30, 2024 was $189M, a 6349% increase year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $189M +$187M +6349% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $28.3M +$11.6M +69.5% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $49.8M +$859K +1.76% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $2.98M -$78.9M -96.4% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $2.94M -$86.1M -96.7% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $16.7M -$72.5M -81.3% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $48.9M +$16M +48.4% Dec 31, 2022 10-K 2024-03-08
Q3 2022 $81.9M Sep 30, 2022 10-Q 2022-11-04
Q2 2022 $89M Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $89.2M Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $33M +$33M Dec 31, 2021 10-K 2023-03-10
Q4 2020 $0 Dec 31, 2020 10-K 2022-03-14
Q1 2017 $2.5M -$5.91M -70.3% Mar 31, 2017 10-Q 2017-05-08
Q4 2016 $5.85M -$4.03M -40.8% Dec 31, 2016 10-Q 2017-02-09
Q3 2016 $8.24M -$1.68M -16.9% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 $13.7M +$4.27M +45.3% Jun 30, 2016 10-Q 2017-05-08
Q1 2016 $8.41M -$244K -2.82% Mar 31, 2016 10-Q 2016-05-06
Q4 2015 $9.88M +$3.95M +66.5% Dec 31, 2015 10-Q 2016-02-09
Q3 2015 $9.92M +$6.99M +239% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 $9.41M +$6.47M +220% Jun 30, 2015 10-K 2016-09-13
Q1 2015 $8.65M +$5.94M +219% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 $5.94M +$5.43M +1082% Dec 31, 2014 10-Q 2015-02-06
Q3 2014 $2.92M +$1.02M +53.2% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 $2.94M -$430K -12.7% Jun 30, 2014 10-K 2015-09-10
Q1 2014 $2.71M -$2.99M -52.4% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 $502K -$5.81M -92% Dec 31, 2013 10-Q 2014-02-12
Q3 2013 $1.91M -$7.35M -79.4% Sep 30, 2013 10-Q 2013-11-13
Q2 2013 $3.37M -$6.57M -66.1% Jun 30, 2013 10-K 2014-09-11
Q1 2013 $5.7M -$4.39M -43.5% Mar 31, 2013 10-Q 2013-05-14
Q4 2012 $6.31M -$3.96M -38.6% Dec 31, 2012 10-Q 2013-02-08
Q3 2012 $9.26M -$2.2M -19.2% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 $9.95M -$1.27M -11.3% Jun 30, 2012 10-K 2013-09-27
Q1 2012 $10.1M Mar 31, 2012 10-Q 2012-05-10
Q4 2011 $10.3M Dec 31, 2011 10-Q 2012-02-09
Q3 2011 $11.5M Sep 30, 2011 10-Q/A 2011-11-09
Q2 2011 $11.2M Jun 30, 2011 10-K 2012-09-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.